Come up with a name for your new list and we'll add to it:
Adamas Pharmaceuticals raised a round of funding on September 16, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Adamas, formerly NeuroMolecular Pharmaceuticals, is a pharmaceutical company focused on developing small molecule, advantaged therapeutics to treat neurological and infectious diseases, including infl…